|
⚲
|
| Sequoia Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001167157 |
| Sale | 2009-06-02 ($5.6 M Offered, $3.8 M Sold) |
| Fund | |
| Phone | 2406320094 |
| Address | 401 Professional Drive Gaithersburg, 20879 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Linda Peters | |
| David Summa | |
| Steve Skolsky | |
| Muzammil Mansuri | |
| Douglas Onsi | |
| Daniel Kisner | |
| John Erickson | |
| Denis Lucquin |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Rockwood Multifamily Partners Feeder LP
✚
|
0.0 | |
|
Rockwood Reiss Fund I, LP
✚
|
0.0 | |
|
Stolper Michael
✚
|
0.0 | |
|
Stoltzfus J Daniel
✚
|
0.0 | |
|
Stolzman Marc D
✚
|
0.0 | |
|
StoneAX Ventures, a Series of Vauban Platform LP
✚
|
0.0 | |
|
Stone Craig
✚
|
0.0 | |
|
Stonecutter Multifamily Fund II-A LP
✚
|
0.0 | |
|
Rocky Mountain Wealth Concepts Hybrid Fund LP
✚
|
0.0 | |
|
Rock Trust (WA 58) M1
✚
|
0.0 |